These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16480403)

  • 1. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
    Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
    Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
    Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
    van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ
    Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication.
    van Grieken NC; Meijer GA; Kale I; Bloemena E; Lindeman J; Offerhaus GJ; Meuwissen SG; Baak JP; Kuipers EJ
    Digestion; 2004; 69(1):27-33. PubMed ID: 14755150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
    Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
    Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.
    Iijima K; Sekine H; Koike T; Imatani A; Ohara S; Shimosegawa T
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1181-8. PubMed ID: 15153171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
    Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
    Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
    Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
    Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
    Lamberts R
    Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Thor K; Andersson A; Hattlebakk J; Havu N; Janatuinen E; Levander K; Liedman B; Nyström P
    Gastroenterology; 1999 Aug; 117(2):319-26. PubMed ID: 10419912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.